Mainz Biomed B.V. Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	16	19	103	122	-	-
Market Cap Growth	-	-81.11%	-15.48%	-	-	-
Enterprise Value	17	19	87	114	1	1
PE Ratio	-0.74	-0.74	-3.90	-10.41	-	-
PS Ratio	20.03	21.70	194.06	210.73	-	-
PB Ratio	5.52	5.98	7.30	19.13	-	-
P/FCF Ratio	-0.81	-0.81	-6.67	-37.59	-	-
P/OCF Ratio	-0.89	-0.89	-6.96	-37.78	-	-
EV/Sales Ratio	19.27	20.93	164.20	196.72	2.10	2.81
EV/EBITDA Ratio	-0.76	-0.76	-3.38	-10.07	-2.97	-1.06
EV/EBIT Ratio	-0.74	-0.74	-3.33	-10.01	-2.53	-0.99
EV/FCF Ratio	-0.79	-0.79	-5.64	-35.09	-2.17	-1.90
Debt / Equity Ratio	1.97	1.97	0.09	0.10	-0.42	-0.51
Debt / EBITDA Ratio	-0.26	-0.26	-0.05	-0.06	-3.32	-1.33
Debt / FCF Ratio	-0.27	-0.27	-0.09	-0.20	-2.43	-2.39
Quick Ratio	0.78	0.78	4.06	6.54	0.24	0.53
Current Ratio	0.97	0.97	4.33	7.11	0.27	0.57
Asset Turnover	0.05	0.05	0.04	0.11	0.71	-
Interest Coverage	-31.48	-31.48	-90.20	-33.47	-2.33	-5.10
Return on Equity (ROE)	-488.00%	-488.00%	-258.00%	-645.90%	25.00%	-
Return on Assets (ROA)	-145.80%	-145.80%	-174.30%	-218.20%	-84.50%	-
Return on Capital (ROIC)	-276.40%	-276.40%	-171.54%	-138.97%	42.63%	96.49%
Earnings Yield	-146.57%	-135.36%	-25.66%	-9.61%	-	-
FCF Yield	-132.87%	-122.70%	-15.00%	-2.66%	-	-
Buyback Yield / Dilution	-14.73%	-14.73%	-96.33%	-28.60%	-	-
Total Shareholder Return	-14.73%	-14.73%	-96.33%	-28.60%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).